Wells Fargo & Company Issues Pessimistic Forecast for Zimmer Biomet (NYSE:ZBH) Stock Price
Zimmer Biomet (NYSE:ZBH – Get Free Report) had its price target lowered by analysts at Wells Fargo & Company from $113.00 to $98.00 in a note issued to investors on Tuesday, MarketBeat reports. The brokerage presently has an “equal weight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s target price indicates a […]
Zimmer Biomet (NYSE:ZBH – Get Free Report) had its price target lowered by analysts at Wells Fargo & Company from $113.00 to $98.00 in a note issued to investors on Tuesday, MarketBeat reports. The brokerage presently has an “equal weight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s target price indicates a […]
-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
